Medios AG Logo

Medios AG

ISIN: DE000A1MMCC8 | Ticker: ILM1 | LEI: 391200Z7Z09IHDBT2L23
Sector: Health CareSub-Industry: Health Care Distributors
Country: Germany

About Medios AG

Company Description

Medios is the competence partner for specialty pharmaceuticals and is one of the leading providers in Germany.

As experts in the supply of medicinal products, the manufacture of patient-specific therapies and drug safety, including blistering, we cover all relevant aspects of the supply chain in the specialty pharma sector. For Medios, the focus is always on an optimal supply to patients via the specialized pharmacy. To this end, we prioritize cooperative partnerships and promote the networking of all players in this special market segment.

Year founded

2008

Served area

Europe

Headcount

249

Headquarters

Heidestraße 9, 10557 Berlin – Germany

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
GER / ENG
ENG
ENG
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
ENG / GER
ENG / GER
GER / ENG
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2020

Report
Q1
H1
Q3
FY
Consolidated Report
ENG / GER
ENG / GER
GER / ENG
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
28.06.23 Prußeit, Christoph Board Buy EUR 39,100.00
09.12.21 Miehler, Mi-Young Board Other EUR 3,550,000.00
09.12.21 Prußeit, Christoph Board Other EUR 1,775,000.00
09.12.21 Miehler, Mi-Young Board Other EUR 700,000.00
09.12.21 Prußeit, Christoph Board Other EUR 350,000.00

Capital markets information

ISIN

DE000A1MMCC8

LEI

391200Z7Z09IHDBT2L23

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Providers & Services

Sub-Industry

Health Care Distributors

Listed Stock Exchange

Frankfurt Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.